Greg Oehrtman

Greg Oehrtman, Ph.D., has a strong background in pharmaceutical development and manufacturing. Greg is currently employed as the VP of Technical Operations at AVEO Oncology, where they lead the development and manufacturing of small molecule drugs and antibodies. Prior to their current role, they worked as a TechOps, CMC, Supply Chain, and Formulation/Device Development Expert at Oehrtman Consulting, LLC. Greg also held the position of Executive Director of DS & DP Manufacturing and Device at Dicerna Pharmaceuticals, Inc. From 2014 to 2020, Greg served as the Executive Director of Formulations, Manufacturing, Supply Chain, Device Development, and Commercial Launch at Stealth BioTherapeutics. Earlier in their career, they held various positions at AVEO Pharmaceuticals, Amylin, Quintiles, and Pfizer Consumer Healthcare. Greg's experience includes expertise in formulation development, clinical manufacturing, process development, and regulatory compliance.

Greg Oehrtman, Ph.D. earned their Bachelor of Science degree in Chemical Engineering from The University of Texas at Austin. Greg then went on to pursue their Master of Science in Chemical Engineering from the University of Illinois Urbana-Champaign. Greg completed their education with a Ph.D. in Chemical Engineering from the prestigious Massachusetts Institute of Technology.